By covering the full spectrum of topics relevant to peptidic drugs, this timely handbook serves as an introductory reference for both drug developers and biomedical researchers interested in pharmaceutically active peptides, presenting both the advantages and challenges associated with this molecula
Peptides as Drugs: Discovery and Development
- Year
- 2009
- Tongue
- English
- Leaves
- 236
- Category
- Library
No coin nor oath required. For personal study only.
โฆ Synopsis
By covering the full spectrum of topics relevant to peptidic drugs, this timely handbook serves as an introductory reference for both drug developers and biomedical researchers interested in pharmaceutically active peptides, presenting both the advantages and challenges associated with this molecular class.
The first part discusses current approaches to developing pharmaceutically active peptides, including case studies of the use of peptidic drugs in cancer and AIDS therapy. The second part surveys strategies for the development and targeting of peptidic drugs.
With its integration of biochemical, pharmaceutical and clinical research, this work reveals the full picture of modern peptide drug research in a single volume, making it an invaluable reference for medicinal chemists, biochemists, biotechnologists, and those in the pharmaceutical and biotechnological industries.Content:
Chapter 1 Peptides as Drugs: Discovery and Development (pages 1โ8): Prof. Dr. Bernd Groner
Chapter 2 Mimics of Growth Factors and Cytokines (pages 9โ34): Jurgen Scheller, Joachim Grotzinger and Stefan Rose?John
Chapter 3 Peptides Derived from Exon v6 of the CD44 Extracellular Domain Prevent Activation of Receptor Tyrosine Kinase and Subsequently Angiogenesis and Metastatic Spread of Tumor Cells (pages 35โ55): Helmut Ponta and Veronique Orian?Rousseau
Chapter 4 Peptide Aptamers Targeting the Viral E6 Oncoprotein Induce Apoptosis in HPV?positive Cancer Cells (pages 57โ72): Felix Hoppe?Seyler, Susanne Dymalla, Markus A. Moosmeier and Karin Hoppe?Seyler
Chapter 5 The Prevention of HIV Infection with Viral Entry Inhibitors (pages 73โ102): Lisa Egerer, Anne Hubert, Dorothee von Laer and Ursula Dietrich
Chapter 6 Intracellular Expression of Peptides (pages 103โ123): Christian Wichmann, Yvonne Becker and Manuel Grez
Chapter 7 The Internalization Mechanisms and Bioactivity of the Cell?Penetrating Peptides (pages 125โ143): Mats Hansen, Elo Eriste and Ulo Langel
Chapter 8 Production and Purification of Monomeric Recombinant Peptide Aptamers: Requirements for Efficient Intracellular Uptake and Target Inhibition (pages 145โ186): Corina Borghouts and Astrid Weiss
Chapter 9 Peptide Arrays on Solid Supports: A Tool for the Identification of Peptide Ligands (pages 187โ217): Mike Schutkowski, Alexandra Thiele and Joachim Koch
๐ SIMILAR VOLUMES
Filling a real knowledge gap, this handbook and ready reference is both modern and forward-looking in its emphasis on the "bench to bedside" translational approach to drug development.Clearly structured into three major parts, the book stakes out the boundaries of peptide drug development in the pre
Peptides are among the most versatile bioactive molecules, yet the do not make good drugs, because they are quickly degraded or modified in the body. To overcome this problem, stable and at the same time biologically active pseudo-peptides have been developed. These novel compounds open up new p
The book that highlights mass spectrometry and its application in characterizing proteins and peptides in drug discoveryAn instrumental analytical method for quantifying the mass and characterization of various samples from small molecules to large proteins, mass spectrometry (MS) has become one of
<P>With potentially high specificity and low toxicity, biologicals offer promising alternatives to small-molecule drugs. Peptide therapeutics have again become the focus of innovative drug development efforts backed up by a resurgence of venture funds and small biotechnology companies. </P><br /><P>